New answers for your digital pharma factory
ケーススタディ：
アストラゼネカがWerumのPAS-Xを使った製造のデジタル化を決定
アストラゼネカのMES分野には紙ベースからさまざまな旧来の多様なシステムがありました。こうした環境を調和化するために、アストラゼネカはWerumを優先サプライヤーとして選択しました。アストラゼネカ標準のMESコアプログラムの目標は、ビジネスプロセスの標準化を進めるための標準やガイドラインに則して共通の技術基盤を使えるようにすることです。ゴールはすべての製造サイトで同じバージョンのソフトウェアを使うことです。これにより開発作業、導入期間および運用費用の削減を図ります。標準化されたPAS-Xの活用によりグローバルレベルでコンテンツや導入サービスの実施が可能となります。
今後のイベント
| Date/Location | Fair |
|---|---|
|
06 Feb - 07 Feb 2019 Paris, France |
Pharmapack |
|
07 Feb - 08 Feb 2019 Madrid, ESP |
2nd Annual Digitalization in Pharma Summit |
|
25 Feb - 27 Feb 2019 London, GBR |
CAR-TCR Summit |
|
01 Apr - 04 Apr 2019 Dublin, Ireland |
ISPE Europe Annual Conference |
|
02 Apr - 04 Apr 2019 New York, NY, USA |
Intephex New York |
PAS-X Newsletter
Cloud-based MES, innovative control concepts, EMI, Pharma 4.0, new reference projects, Self-Service Portal, cell therapy, data integrity
In our Newsletter we show you, how we have brought three game-changing ideas into reality: PAS-X as a Service – our market-leading MES in the cloud, innovative operating concepts – AR, wearables and voice-directed technology, and our new Enterprise Manufacturing Intelligence solutions. Learn more about how we apply Industrie 4.0 technologies to pharma manufacturing and which Pharma 4.0 solutions we offer. In addition to an update on our latest customer projects, you will also find out more about our new Self-Service Portal, our offering for cell therapy manufacturer, and data integrity.
From Industry 4.0 to Pharma 4.0: ISPE Article of the Year
The current submission-based control strategy does not consider GMP, facilities, equipment and other production-specific controls to mitigate risk and ensure an effective, reliable production process. Transforming today’s control strategy to commercial manufacturing by technology transfer and scaling requires a best practice methodology that will change the current control strategy into a holistic production control strategy.
In their article, which received the ISPE 2017 Article of the Year award, the authors Christoph Herwig, Christian Wölbeling and Thomas Zimmer identify the need for a redefined control strategy implementation methodology.
Read more at Pharmaceutical Engineering
